CLINICAL_TRIALS
trial_result
· 2019-02-04
Clinical Trial Update: Dynamic Substrate Mapping (DSM) for Ischemic VT [Phase 1]
Summary
Abbott Medical Devices' Phase 1 trial of Dynamic Substrate Mapping for ischemic ventricular tachycardia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Abbott Medical Devices | Conditions: Ischemic Ventricular Tachycardia | Phase 1 | Status: TERMINATED